Opioids and non-steroidal anti-inflammatory drugs (NSAIDs) are used to relieve acute
and chronic pain. The purpose of this study was to determine the degree of interaction
between dexketoprofen and NSAID examples of COXs inhibitors using the isobolographic
analysis in the formalin orofacial test in mice. The drugs, i.p., induced a dose-dependent
antinociception with different potencies in both test phases. Combinations of dexketoprofen
with naproxen, nimesulide, ibuprofen or paracetamol on the basis of the fixed ratio
(1:1) of their ED(50)'s values alone demonstrated synergism in both phases. This is
important since the orofacial pain is a test not currently used in mice; the drugs
are all analgesic for humans and phase II is representative of inflammatory pain.
The synergism was: COX-3>COX-2>COX-1 inhibitors, this is particularly interesting
since the inhibitor of COX-3, paracetamol, displayed a robust anti-inflammatory activity
in an assay of acute and inflammatory pain that mimics inflammatory pain in humans.
In conclusion, the synergism of the dexketoprofen/NSAID combinations may improve this
type of therapeutic profile, since with low doses of the components, side effects
are not likely to occur, and they may be used in long-term treatments.